Senior Director, Global Regulatory CMC- Drug- Device Combination Products jobs in United States
cer-icon
Apply on Employer Site
company-logo

Biogen · 3 days ago

Senior Director, Global Regulatory CMC- Drug- Device Combination Products

Biogen is a mid-sized biotechnology company committed to excellence and innovation. As the Senior Director, Global Regulatory CMC - Drug-Device Combination Products, you will lead the regulatory strategy for the global device and combination product portfolio, ensuring compliance and influencing regulatory policy to support patient supply continuity.

BiotechnologyHealth CareNeuroscienceTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Define and own the global regulatory CMC strategy for drug-device combination products, diagnostics, and medical devices
Serve as the primary regulatory authority for complex, high-risk programs for all non-implantable device programs
Lead global regulatory strategy development and execution across development, registration, commercialization, and lifecycle management
Ensure quality, consistency, and timeliness of global CMC regulatory submissions across all regions
Act as the senior regulatory representative with global Health Authorities for device and combination product portfolios
Mentor and develop senior leaders and regulatory experts, fostering a culture of accountability and strategic thinking
Provide executive regulatory leadership for quality systems oversight, including change control and deviation management
Standardize processes and embed best practices to improve efficiency and scalability
Represent Biogen in external industry forums and influence regulatory standards and paradigms

Qualification

Global Regulatory CMC StrategyRegulatory LeadershipHealth Authority EngagementsDevice-Combination ProductsHigh-Performing TeamsLifecycle Management StrategiesMentoringStrategic ThinkingCollaboration

Required

Bachelor's degree and 15+ years of industry experience in Medical Device and Combination Product Regulatory Affairs with at least 10 years of experience leading global regulatory organizations within pharmaceutical or biotechnology environments
Demonstrated regulatory leadership across Class II devices, In-Vitro Diagnostics, and Digital Health Solutions
Extensive experience leading global Health Authority engagements and negotiations
Proven ability to influence enterprise strategy, governance, and industry standards
Strong track record of building, scaling, and sustaining high-performing global teams
Expert knowledge of evolving regulatory expectations for device and combination product licensure

Preferred

Advanced degree in life sciences, engineering, biotechnology, law, or pharmaceutical sciences
Experience with lifecycle management strategies and differentiated drug-device combination products

Benefits

Medical, Dental, Vision, & Life insurances
Fitness & Wellness programs including a fitness reimbursement
Short- and Long-Term Disability insurance
A minimum of 15 days of paid vacation and an additional end-of-year shutdown time off (Dec 26-Dec 31)
Up to 12 company paid holidays + 3 paid days off for Personal Significance
80 hours of sick time per calendar year
Paid Maternity and Parental Leave benefit
401(k) program participation with company matched contributions
Employee stock purchase plan
Tuition reimbursement of up to $10,000 per calendar year
Employee Resource Groups participation

Company

Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.

H1B Sponsorship

Biogen has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (100)
2024 (93)
2023 (101)
2022 (134)
2021 (104)
2020 (114)

Funding

Current Stage
Public Company
Total Funding
$1.5B
Key Investors
JP Morgan
2023-08-28Post Ipo Debt· $1.5B
1991-09-27IPO

Leadership Team

leader-logo
Robin C. Kramer
Executive Vice President, Chief Financial Officer
linkedin
leader-logo
Priya Singhal
Executive Vice President, Head of Development
linkedin
Company data provided by crunchbase